Research Tracker›Biomarker Atlas›Asthma›25-Hydroxyvitamin D

25-Hydroxyvitamin D in Asthma

25-Hydroxyvitamin D belongs to the other group of Asthma markers, but reports against obese asthmatic children with sufficient vitamin D point in different directions. Clinically, it has been associated with lower Forced Expiratory Volume in the first second, lower Functional Residual Capacity, lower Total Lung Capacity. This entry summarises Lautenbacher et al. 2016. Group-level associations like this do not translate into an individual diagnostic cut-off.

↕ InconsistentOther

Summary

Direction in Asthma↕ Inconsistent — reported as both higher and lower across studies, with no consistent direction
CategoryOther
Compared againstobese asthmatic children with sufficient vitamin D
Associated symptomslower Forced Expiratory Volume in the first second, lower Functional Residual Capacity, lower Total Lung Capacity
SourceLautenbacher et al. 2016 — doi:10.1002/ppul.23485
Condition atlasAsthma Biomarker Atlas

Other conditions where 25-Hydroxyvitamin D is reported

See the cross-condition hub: 25-Hydroxyvitamin D across conditions.

Related Other markers in Asthma

Full list: Asthma Biomarker Atlas.

Frequently asked questions

Is 25-Hydroxyvitamin D high or low in Asthma?

Mixed. Some studies report higher and others lower 25-Hydroxyvitamin D in Asthma compared with obese asthmatic children with sufficient vitamin D, so no single direction is established. Source: Lautenbacher et al. 2016.

What symptoms is 25-Hydroxyvitamin D associated with in Asthma?

The cited literature associates this marker with lower Forced Expiratory Volume in the first second, lower Functional Residual Capacity, lower Total Lung Capacity. These are population-level associations and do not mean the marker causes the symptoms.

Which test measures 25-Hydroxyvitamin D?

The atlas record does not list a standardised clinical test code (LOINC) for 25-Hydroxyvitamin D, which usually means it was measured with research assays or study-specific protocols rather than a routine clinical panel. Check the cited source for the exact method.

Is one abnormal 25-Hydroxyvitamin D result diagnostic of Asthma?

No. No single biomarker is diagnostic of Asthma. 25-Hydroxyvitamin D findings come from group comparisons, overlap considerably between patients and controls, and vary with study design, timing and comparison group. A result should be interpreted by a clinician alongside symptoms, history and other tests.

Is 25-Hydroxyvitamin D specific to Asthma?

No. The same marker is also reported in Low Back Pain, Major Depressive Disorder, Migraine, Multiple Sclerosis in this atlas, so it reflects shared biology (for example inflammation or vascular stress) rather than a condition-specific signature.

Cite this page

Open Source Medicine Foundation. (2026). 25-Hydroxyvitamin D in Asthma: direction, evidence and what it means. OSMF Research Tracker. Retrieved October 8, 2026, from https://research.opensourcemed.info/biomarkers/asthma/25-hydroxyvitamin-d.html
Get OSMF research updates. New biomarker, trial and treatment evidence summaries by email.
Subscribe on Substack

Last reviewed: 2026-10-08 · Page generated from asthma.json · Browse: Asthma atlas · Biomarker Index · All marker pages

Disclaimer: This page is an educational synthesis of published, peer-reviewed research and is not medical advice. Biomarker findings vary across studies with case definitions, comparison groups, timing and assay methods. Direction of change reflects the predominant finding in the cited source and does not establish a diagnostic threshold. Discuss any test result with a qualified clinician.